FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309722966> ?p ?o ?g. }

• W4309722966 endingPage "5750" @default.
• W4309722966 startingPage "5750" @default.
• W4309722966 abstract "Chronic lymphocytic leukemia patients have an increased bleeding risk with the introduction of Bruton tyrosine kinase (BTK) inhibitors. BTK is a signaling effector downstream of the platelet GPVI receptor. Innate platelet dysfunction in CLL patients and the contribution of the leukemia microenvironment to the anti-platelet effect of BTK inhibitors are still not well defined. Herein, we investigated platelet function in stable, untreated CLL patients in comparison to age-matched healthy subjects as control. Secondly, we proposed a novel mechanism of platelet dysfunction via the adenosinergic pathway during BTK inhibitor therapy. Our data indicate that the nucleotidase that produces adenosine, CD73, was expressed on one-third of B-cells in CLL patients. Inhibition of CD73 improved platelet response to ADP in the blood of CLL patients ex vivo. Using healthy platelets, we show that adenosine 2A (A2A) receptor activation amplifies the anti-platelet effect of ibrutinib (10 nM). Ibrutinib plus an A2A agonist—but not ibrutinib as a single agent—significantly inhibited collagen (10 µg/mL)-induced platelet aggregation. Mechanistically, A2A activation attenuated collagen-mediated inhibition of p-VASP and synergized with ibrutinib to inhibit the phosphorylation of AKT, ERK and SYK kinases. This manuscript highlights the potential role of adenosine generated by the microenvironment in ibrutinib-associated bleeding in CLL patients." @default.
• W4309722966 created "2022-11-29" @default.
• W4309722966 creator A5007144926 @default.
• W4309722966 creator A5036747329 @default.
• W4309722966 creator A5066919195 @default.
• W4309722966 creator A5085118645 @default.
• W4309722966 creator A5089908393 @default.
• W4309722966 date "2022-11-23" @default.
• W4309722966 modified "2023-10-14" @default.
• W4309722966 title "Adenosine 2A Receptor Activation Amplifies Ibrutinib Antiplatelet Effect; Implications in Chronic Lymphocytic Leukemia" @default.
• W4309722966 cites W1517642606 @default.
• W4309722966 cites W1964842624 @default.
• W4309722966 cites W1965314978 @default.
• W4309722966 cites W1976225087 @default.
• W4309722966 cites W1979834961 @default.
• W4309722966 cites W1993717621 @default.
• W4309722966 cites W2018768806 @default.
• W4309722966 cites W2021041611 @default.
• W4309722966 cites W2022840466 @default.
• W4309722966 cites W2025707347 @default.
• W4309722966 cites W2028786759 @default.
• W4309722966 cites W2038486247 @default.
• W4309722966 cites W2041872039 @default.
• W4309722966 cites W2048754984 @default.
• W4309722966 cites W2054220445 @default.
• W4309722966 cites W2059275547 @default.
• W4309722966 cites W2063407553 @default.
• W4309722966 cites W2067064694 @default.
• W4309722966 cites W2086556660 @default.
• W4309722966 cites W2095631860 @default.
• W4309722966 cites W2096419264 @default.
• W4309722966 cites W2141880470 @default.
• W4309722966 cites W2150447839 @default.
• W4309722966 cites W2158602811 @default.
• W4309722966 cites W2163690533 @default.
• W4309722966 cites W2169084734 @default.
• W4309722966 cites W2256135779 @default.
• W4309722966 cites W2316021978 @default.
• W4309722966 cites W2338436382 @default.
• W4309722966 cites W2342094689 @default.
• W4309722966 cites W2505567457 @default.
• W4309722966 cites W2520598873 @default.
• W4309722966 cites W2565882929 @default.
• W4309722966 cites W2575232065 @default.
• W4309722966 cites W2587387808 @default.
• W4309722966 cites W2744761285 @default.
• W4309722966 cites W2788356134 @default.
• W4309722966 cites W2803700801 @default.
• W4309722966 cites W2807619077 @default.
• W4309722966 cites W2883175618 @default.
• W4309722966 cites W2902815908 @default.
• W4309722966 cites W2914323946 @default.
• W4309722966 cites W2919444768 @default.
• W4309722966 cites W2946892150 @default.
• W4309722966 cites W2959572112 @default.
• W4309722966 cites W2976370454 @default.
• W4309722966 cites W3031304050 @default.
• W4309722966 cites W3033667097 @default.
• W4309722966 cites W3212119324 @default.
• W4309722966 cites W4251179777 @default.
• W4309722966 doi "https://doi.org/10.3390/cancers14235750" @default.
• W4309722966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36497231" @default.
• W4309722966 hasPublicationYear "2022" @default.
• W4309722966 type Work @default.
• W4309722966 citedByCount "0" @default.
• W4309722966 crossrefType "journal-article" @default.
• W4309722966 hasAuthorship W4309722966A5007144926 @default.
• W4309722966 hasAuthorship W4309722966A5036747329 @default.
• W4309722966 hasAuthorship W4309722966A5066919195 @default.
• W4309722966 hasAuthorship W4309722966A5085118645 @default.
• W4309722966 hasAuthorship W4309722966A5089908393 @default.
• W4309722966 hasBestOaLocation W43097229661 @default.
• W4309722966 hasConcept C126322002 @default.
• W4309722966 hasConcept C170493617 @default.
• W4309722966 hasConcept C185592680 @default.
• W4309722966 hasConcept C203014093 @default.
• W4309722966 hasConcept C2776991684 @default.
• W4309722966 hasConcept C2776992512 @default.
• W4309722966 hasConcept C2777938653 @default.
• W4309722966 hasConcept C2778461978 @default.
• W4309722966 hasConcept C2778491162 @default.
• W4309722966 hasConcept C2778938600 @default.
• W4309722966 hasConcept C2779878957 @default.
• W4309722966 hasConcept C3018697912 @default.
• W4309722966 hasConcept C35174551 @default.
• W4309722966 hasConcept C42362537 @default.
• W4309722966 hasConcept C502942594 @default.
• W4309722966 hasConcept C67907053 @default.
• W4309722966 hasConcept C71924100 @default.
• W4309722966 hasConcept C89560881 @default.
• W4309722966 hasConcept C90059517 @default.
• W4309722966 hasConcept C98274493 @default.
• W4309722966 hasConceptScore W4309722966C126322002 @default.
• W4309722966 hasConceptScore W4309722966C170493617 @default.
• W4309722966 hasConceptScore W4309722966C185592680 @default.
• W4309722966 hasConceptScore W4309722966C203014093 @default.
• W4309722966 hasConceptScore W4309722966C2776991684 @default.
• W4309722966 hasConceptScore W4309722966C2776992512 @default.

• next